Furthermore, Kaut et al. (2012) reported a decreased methylation of CYP2E1 and increased expression of CYP2E1 messenger RNA in patients with Parkinson’s disease, suggesting that epigenetic variants of this cytochrome contribute to Parkinson’s disease susceptibility [35]. The gene discussed is CYP2E1; the disease is Parkinson disease.